bf/NASDAQ:ANTX_icon.jpeg

COM:AN2THERAPEUTICS

AN2 Therapeutics

  • Stock

USD

Last Close

1.23

22/11 21:00

Market Cap

77.56M

Beta: -

Volume Today

1.25M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-5.63M
-
-13.60M
141.40%
-21.54M
58.37%
-40.96M
90.11%
-64.73M
58.05%
depreciation and amortization
-692K
-
deferred income tax
stock based compensation
40K
-
974K
2,335%
4.39M
350.82%
8.41M
91.57%
change in working capital
-10K
-
1.22M
12,340%
32K
97.39%
3.72M
11,518.75%
5.83M
56.91%
accounts receivables
inventory
accounts payables
-16K
-
81K
606.25%
417K
414.81%
2.50M
498.80%
553K
77.85%
other working capital
6K
-
1.14M
18,950%
-385K
133.68%
1.22M
417.14%
5.28M
332.51%
other non cash items
3.16M
-
6.97M
120.80%
53K
99.24%
77K
45.28%
-2.80M
3,738.96%
net cash provided by operating activities
-2.49M
-
-5.36M
115.77%
-20.48M
281.88%
-33.46M
63.36%
-53.29M
59.25%
investments in property plant and equipment
acquisitions net
purchases of investments
-77.27M
-
-93.84M
21.43%
-132.18M
40.86%
sales maturities of investments
27.25M
-
72.06M
164.46%
88.90M
23.36%
other investing activites
net cash used for investing activites
-50.02M
-
-21.77M
56.48%
-43.28M
98.79%
debt repayment
-11K
-
common stock issued
8.08M
-
3.84M
52.55%
78.53M
1,947.31%
70.37M
10.40%
84.99M
20.79%
common stock repurchased
-11K
-
dividends paid
-1.82M
-
other financing activites
48.50K
-
3.84K
92.09%
1.83M
-
19.52M
965.81%
net cash used provided by financing activities
8.08M
-
3.84M
52.55%
78.53M
1,947.31%
70.36M
10.42%
84.99M
20.81%
effect of forex changes on cash
net change in cash
5.60M
-
-1.53M
127.30%
8.03M
625.33%
15.12M
88.39%
-11.57M
176.52%
cash at beginning of period
5.60M
-
4.07M
27.30%
12.10M
197.22%
27.22M
125.01%
cash at end of period
5.60M
-
4.07M
27.30%
12.10M
197.22%
27.22M
125.01%
15.65M
42.51%
operating cash flow
-2.49M
-
-5.36M
115.77%
-20.48M
281.88%
-33.46M
63.36%
-53.29M
59.25%
capital expenditure
free cash flow
-2.49M
-
-5.36M
115.77%
-20.48M
281.88%
-33.46M
63.36%
-53.29M
59.25%

All numbers in USD (except ratios and percentages)